Capstan Medical secures $110m for robotic-assisted heart valve implants
Capstan Medical has raised $110m to advance its robotic platform for cardiac disease treatment in one of the larger medtech …
Capstan Medical has raised $110m to advance its robotic platform for cardiac disease treatment in one of the larger medtech …
Roche has received the CE mark certification for its newly updated cobas 6800/8800 systems 2.0, improving laboratories and testing capabilities. The …
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Johnson & Johnson (J&J) MedTech’s Impella 5.5 …
Natera has begun the subject enrolment in the randomised Phase III SAGITTARIUS clinical trial designed to assess the Signatera test …
FemPulse is set to enter the pivotal clinical trial phase with its neuromodulation system to treat overactive bladder after the …
The US Food and Drug Administration (FDA) has issued an early alert over a potential high-risk issue with Fresenius Kabi’s …
Osteotec has signed an exclusive agreement for the distribution of Cerapedics' i-FACTOR bone graft portfolio in Ireland and the UK. The …
New legislation is being laid in the UK Parliament today (12 December) that will change the regulatory framework for clinical …
US-based bone adhesive company RevBio has received approval from the US Food and Drug Administration (FDA) to expand an ongoing …
Bausch + Lomb has announced the acquisition of Elios Vision by an affiliate to improve the company's capabilities in treating …
SamanTree Medical has revealed that its Histolog scanner, a confocal laser microscope, significantly decreased breast-conserving surgery (BCS) reoperation rates by …
US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with …
President-elect Donald Trump campaigned in 2024 on a chaotic platform that included promises to roll back access to gender-affirming care …
EndoQuest Robotics has won an investigational device exemption (IDE) from the US Food and Drug Administration (FDA), allowing the company …
MeMed has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its MeMed Severity test, …